⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31356399 | 0.73 | — | — | |
| SCHEMBL4073685 | 0.71 | — | — | |
| SCHEMBL28673682 | 0.69 | TSHR (0.32) | — | |
| SCHEMBL27414399 | 0.69 | LMNA (0.32) | — | |
| SCHEMBL5672376 | 0.69 | — | — | |
| SCHEMBL1701374 | 0.69 | — | — | |
| SCHEMBL28613075 | 0.69 | SMN1; SMN2 (0.32) | — | |
| Hydrogen Sulfide SCHEMBL27522910 | 0.69 | — | — | |
| Water SCHEMBL8221741 | 0.69 | — | — | |
| Water SCHEMBL27524007 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1972932-A | Compounds and methods for treating dyslipidemia | LILLY CO ELI (US) | 2007-05-30 | — | — | CN | disclosed |
| CN-1863778-A | Compounds and methods for treating dyslipidemia | LILLY CO ELI (US) | 2006-11-15 | — | — | CN | disclosed |